(State or other jurisdiction | (Commission | (IRS Employer |
of incorporation) | File Number) | Identification Number) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | |
Emerging growth company | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
Exhibit Number | Exhibit Description | |
99.1 | ||
101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | |
101.SCH | Inline XBRL Taxonomy Extension Schema Document | |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | |
104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
Huron Consulting Group Inc. | |||
(Registrant) | |||
Date: | July 30, 2020 | /s/ John D. Kelly | |
John D. Kelly | |||
Executive Vice President, Chief Financial Officer, and Treasurer |
NEWS | MEDIA CONTACT | |
Allie Bovis | ||
FOR IMMEDIATE RELEASE | abovis@huronconsultinggroup.com | |
INVESTOR CONTACT | ||
John D. Kelly | ||
investor@huronconsultinggroup.com |
• | Revenues were $217.9 million in Q2 2020 compared to $220.8 million in Q2 2019. |
• | Net income from continuing operations increased $3.0 million, or 28.4%, to $13.6 million in Q2 2020 from $10.6 million in Q2 2019. |
• | Adjusted EBITDA(7), a non-GAAP measure, was $27.5 million in Q2 2020 compared to $29.2 million in Q2 2019. |
• | Diluted earnings per share from continuing operations increased $0.14, or 29.8%, to $0.61 in Q2 2020 from $0.47 in Q2 2019. |
• | Adjusted diluted earnings per share from continuing operations(7), a non-GAAP measure, was $0.68 in Q2 2020 compared to $0.76 in Q2 2019. |
• | Huron repaid $120.0 million of outstanding borrowings on the company's revolving credit facility during Q2 2020, reflecting strong cash flows during the quarter. |
• | Revenues increased $15.3 million, or 3.6%, to $440.5 million for the first six months of 2020 from $425.2 million for the same prior year period. |
• | Net loss from continuing operations, which includes non-cash pretax goodwill impairment charges of $59.8 million related to the company's Business Advisory segment incurred in Q1 2020, was $28.7 million for the first six months of 2020 compared to net income from continuing operations of $13.9 million for the same prior year period. |
• | Adjusted EBITDA(7), a non-GAAP measure, was $46.5 million for the the first six months of 2020 compared to $47.2 million for the same prior year period. |
• | Diluted loss per share from continuing operations was $1.31 for the first six months of 2020 compared to diluted earnings per share from continuing operations of $0.62 for the first six months of 2019. |
• | Adjusted diluted earnings per share from continuing operations(7), a non-GAAP measure, was $1.11 for the first six months of 2020 compared to $1.16 for the first six months of 2019. |
• | Huron provides full year 2020 guidance, including revenue expectations in a range of $820 million to $860 million. |
Three Months Ended June 30, | |||||||
2020 | 2019 | ||||||
Amortization of intangible assets | $ | 3,194 | $ | 4,314 | |||
Restructuring and other charges | $ | 109 | $ | 754 | |||
Litigation and other gains | $ | — | $ | (485 | ) | ||
Non-cash interest on convertible notes | $ | — | $ | 2,145 | |||
Transaction-related expenses | $ | — | $ | 2,050 | |||
Tax effect of adjustments | $ | (1,940 | ) | $ | (2,282 | ) | |
Foreign currency transaction losses (gains), net | $ | (81 | ) | $ | 4 |
Six Months Ended June 30, | |||||||
2020 | 2019 | ||||||
Amortization of intangible assets | $ | 6,403 | $ | 8,831 | |||
Restructuring and other charges | $ | 2,567 | $ | 2,029 | |||
Litigation and other gains | $ | (150 | ) | $ | (941 | ) | |
Goodwill impairment charges | $ | 59,816 | $ | — | |||
Non-cash interest on convertible notes | $ | — | $ | 4,265 | |||
Loss on sale of business | $ | 102 | $ | — | |||
Transaction-related expenses | $ | — | $ | 2,050 | |||
Tax effect of adjustments | $ | (15,349 | ) | $ | (4,235 | ) | |
Foreign currency transaction losses, net | $ | 439 | $ | (78 | ) |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2020 | 2019 | 2020 | 2019 | ||||||||||||
Revenues and reimbursable expenses: | |||||||||||||||
Revenues | $ | 217,857 | $ | 220,754 | $ | 440,476 | $ | 425,199 | |||||||
Reimbursable expenses | 2,970 | 23,534 | 22,273 | 42,151 | |||||||||||
Total revenues and reimbursable expenses | 220,827 | 244,288 | 462,749 | 467,350 | |||||||||||
Direct costs and reimbursable expenses (exclusive of depreciation and amortization shown in operating expenses): | |||||||||||||||
Direct costs | 149,514 | 141,628 | 305,762 | 279,408 | |||||||||||
Amortization of intangible assets and software development costs | 1,334 | 1,171 | 2,635 | 2,288 | |||||||||||
Reimbursable expenses | 2,866 | 23,657 | 22,255 | 42,326 | |||||||||||
Total direct costs and reimbursable expenses | 153,714 | 166,456 | 330,652 | 324,022 | |||||||||||
Operating expenses and other losses (gains), net: | |||||||||||||||
Selling, general and administrative expenses | 44,857 | 52,537 | 88,303 | 103,286 | |||||||||||
Restructuring charges | 109 | 754 | 1,718 | 2,029 | |||||||||||
Litigation and other gains | — | (485 | ) | (150 | ) | (941 | ) | ||||||||
Depreciation and amortization | 6,193 | 7,151 | 12,307 | 14,323 | |||||||||||
Goodwill impairment charges | — | — | 59,816 | — | |||||||||||
Total operating expenses and other losses (gains), net | 51,159 | 59,957 | 161,994 | 118,697 | |||||||||||
Operating income (loss) | 15,954 | 17,875 | (29,897 | ) | 24,631 | ||||||||||
Other income (expense), net: | |||||||||||||||
Interest expense, net of interest income | (2,916 | ) | (4,524 | ) | (5,257 | ) | (8,782 | ) | |||||||
Other income (expense), net | 3,948 | 695 | (1,348 | ) | 2,912 | ||||||||||
Total other income (expense), net | 1,032 | (3,829 | ) | (6,605 | ) | (5,870 | ) | ||||||||
Income (loss) from continuing operations before taxes | 16,986 | 14,046 | (36,502 | ) | 18,761 | ||||||||||
Income tax expense (benefit) | 3,414 | 3,477 | (7,801 | ) | 4,842 | ||||||||||
Net income (loss) from continuing operations | 13,572 | 10,569 | (28,701 | ) | 13,919 | ||||||||||
Loss from discontinued operations, net of tax | (25 | ) | (97 | ) | (60 | ) | (143 | ) | |||||||
Net income (loss) | $ | 13,547 | $ | 10,472 | $ | (28,761 | ) | $ | 13,776 | ||||||
Net earnings (loss) per basic share: | |||||||||||||||
Net income (loss) from continuing operations | $ | 0.62 | $ | 0.48 | $ | (1.31 | ) | $ | 0.63 | ||||||
Loss from discontinued operations, net of tax | — | — | (0.01 | ) | — | ||||||||||
Net income (loss) | $ | 0.62 | $ | 0.48 | $ | (1.32 | ) | $ | 0.63 | ||||||
Net earnings (loss) per diluted share: | |||||||||||||||
Net income (loss) from continuing operations | $ | 0.61 | $ | 0.47 | $ | (1.31 | ) | $ | 0.62 | ||||||
Loss from discontinued operations, net of tax | — | — | (0.01 | ) | — | ||||||||||
Net income (loss) | $ | 0.61 | $ | 0.47 | $ | (1.32 | ) | $ | 0.62 | ||||||
Weighted average shares used in calculating earnings (loss) per share: | |||||||||||||||
Basic | 21,869 | 21,997 | 21,848 | 21,933 | |||||||||||
Diluted | 22,116 | 22,400 | 21,848 | 22,356 | |||||||||||
Comprehensive income: | |||||||||||||||
Net income (loss) | $ | 13,547 | $ | 10,472 | $ | (28,761 | ) | $ | 13,776 | ||||||
Foreign currency translation adjustments, net of tax | 104 | (359 | ) | (675 | ) | (43 | ) | ||||||||
Unrealized gain (loss) on investment, net of tax | (5,678 | ) | 3,915 | (5,936 | ) | 6,572 | |||||||||
Unrealized loss on cash flow hedging instruments, net of tax | (1,705 | ) | (612 | ) | (3,390 | ) | (849 | ) | |||||||
Other comprehensive income (loss) | (7,279 | ) | 2,944 | (10,001 | ) | 5,680 | |||||||||
Comprehensive income (loss) | $ | 6,268 | $ | 13,416 | $ | (38,762 | ) | $ | 19,456 |
June 30, 2020 | December 31, 2019 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 83,212 | $ | 11,604 | |||
Receivables from clients, net | 117,632 | 116,571 | |||||
Unbilled services, net | 82,932 | 79,937 | |||||
Income tax receivable | 323 | 2,376 | |||||
Prepaid expenses and other current assets | 13,863 | 14,248 | |||||
Total current assets | 297,962 | 224,736 | |||||
Property and equipment, net | 37,082 | 38,413 | |||||
Deferred income taxes, net | 12,426 | 1,145 | |||||
Long-term investments | 59,524 | 54,541 | |||||
Operating lease right-of-use assets | 52,298 | 54,954 | |||||
Other non-current assets | 55,083 | 52,177 | |||||
Intangible assets, net | 24,916 | 31,625 | |||||
Goodwill | 586,235 | 646,680 | |||||
Total assets | $ | 1,125,526 | $ | 1,104,271 | |||
Liabilities and stockholders’ equity | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 5,046 | $ | 7,944 | |||
Accrued expenses and other current liabilities | 23,532 | 18,554 | |||||
Accrued payroll and related benefits | 80,066 | 141,605 | |||||
Current maturities of long-term debt | 536 | 529 | |||||
Current maturities of operating lease liabilities | 8,559 | 7,469 | |||||
Deferred revenues | 35,044 | 28,443 | |||||
Total current liabilities | 152,783 | 204,544 | |||||
Non-current liabilities: | |||||||
Deferred compensation and other liabilities | 38,557 | 28,635 | |||||
Long-term debt, net of current portion | 331,054 | 208,324 | |||||
Operating lease liabilities, net of current portion | 66,547 | 69,233 | |||||
Deferred income taxes, net | 571 | 8,070 | |||||
Total non-current liabilities | 436,729 | 314,262 | |||||
Commitments and contingencies | |||||||
Stockholders’ equity | |||||||
Common stock; $0.01 par value; 500,000,000 shares authorized; 25,421,974 and 25,144,764 shares issued at June 30, 2020 and December 31, 2019, respectively | 246 | 247 | |||||
Treasury stock, at cost, 2,556,012 and 2,425,430 shares at June 30, 2020 and December 31, 2019, respectively | (128,646 | ) | (128,348 | ) | |||
Additional paid-in capital | 450,391 | 460,781 | |||||
Retained earnings | 209,088 | 237,849 | |||||
Accumulated other comprehensive income | 4,935 | 14,936 | |||||
Total stockholders’ equity | 536,014 | 585,465 | |||||
Total liabilities and stockholders’ equity | $ | 1,125,526 | $ | 1,104,271 |
Six Months Ended June 30, | |||||||
2020 | 2019 | ||||||
Cash flows from operating activities: | |||||||
Net income (loss) | $ | (28,761 | ) | $ | 13,776 | ||
Adjustments to reconcile net income (loss) to cash flows from operating activities: | |||||||
Depreciation and amortization | 14,942 | 17,285 | |||||
Non-cash lease expense | 3,880 | 4,397 | |||||
Lease impairment charge | — | 805 | |||||
Share-based compensation | 14,527 | 11,483 | |||||
Amortization of debt discount and issuance costs | 397 | 5,264 | |||||
Goodwill impairment charges | 59,816 | — | |||||
Allowances for doubtful accounts | 512 | 170 | |||||
Deferred income taxes | (15,515 | ) | — | ||||
Loss on sale of business | 102 | — | |||||
Change in fair value of contingent consideration liabilities | — | (876 | ) | ||||
Changes in operating assets and liabilities, net of divestiture: | |||||||
(Increase) decrease in receivables from clients, net | (339 | ) | (6,984 | ) | |||
(Increase) decrease in unbilled services, net | (3,059 | ) | (22,105 | ) | |||
(Increase) decrease in current income tax receivable / payable, net | 6,546 | 6,486 | |||||
(Increase) decrease in other assets | (1,674 | ) | (4,743 | ) | |||
Increase (decrease) in accounts payable and other liabilities | (2,787 | ) | (133 | ) | |||
Increase (decrease) in accrued payroll and related benefits | (53,420 | ) | (30,462 | ) | |||
Increase (decrease) in deferred revenues | 6,638 | (570 | ) | ||||
Net cash provided by (used in) operating activities | 1,805 | (6,207 | ) | ||||
Cash flows from investing activities: | |||||||
Purchases of property and equipment, net | (4,417 | ) | (6,384 | ) | |||
Purchases of investment securities | (13,000 | ) | — | ||||
Investment in life insurance policies | (1,540 | ) | (4,087 | ) | |||
Capitalization of internally developed software costs | (5,184 | ) | (4,409 | ) | |||
Net cash used in investing activities | (24,141 | ) | (14,880 | ) | |||
Cash flows from financing activities: | |||||||
Proceeds from exercise of stock options | 646 | 469 | |||||
Shares redeemed for employee tax withholdings | (7,217 | ) | (4,460 | ) | |||
Share repurchases | (22,115 | ) | — | ||||
Proceeds from bank borrowings | 283,000 | 87,500 | |||||
Repayments of bank borrowings | (160,263 | ) | (81,756 | ) | |||
Payments for contingent consideration liabilities | — | (4,674 | ) | ||||
Net cash provided by (used in) financing activities | 94,051 | (2,921 | ) | ||||
Effect of exchange rate changes on cash | (107 | ) | 78 | ||||
Net increase (decrease) in cash and cash equivalents | 71,608 | (23,930 | ) | ||||
Cash and cash equivalents at beginning of the period | 11,604 | 33,107 | |||||
Cash and cash equivalents at end of the period | $ | 83,212 | $ | 9,177 |
Three Months Ended June 30, | Percent Increase (Decrease) | ||||||||||
Segment and Consolidated Operating Results (in thousands): | 2020 | 2019 | |||||||||
Healthcare: | |||||||||||
Revenues | $ | 85,356 | $ | 101,939 | (16.3 | )% | |||||
Operating income | $ | 21,171 | $ | 33,344 | (36.5 | )% | |||||
Segment operating income as a percentage of segment revenues | 24.8 | % | 32.7 | % | |||||||
Business Advisory: | |||||||||||
Revenues | $ | 70,470 | $ | 62,277 | 13.2 | % | |||||
Operating income | $ | 16,684 | $ | 11,474 | 45.4 | % | |||||
Segment operating income as a percentage of segment revenues | 23.7 | % | 18.4 | % | |||||||
Education: | |||||||||||
Revenues | $ | 62,031 | $ | 56,538 | 9.7 | % | |||||
Operating income | $ | 16,128 | $ | 16,204 | (0.5 | )% | |||||
Segment operating income as a percentage of segment revenues | 26.0 | % | 28.7 | % | |||||||
Total Company: | |||||||||||
Revenues | $ | 217,857 | $ | 220,754 | (1.3 | )% | |||||
Reimbursable expenses | 2,970 | 23,534 | (87.4 | )% | |||||||
Total revenues and reimbursable expenses | $ | 220,827 | $ | 244,288 | (9.6 | )% | |||||
Statements of Operations reconciliation: | |||||||||||
Segment operating income | $ | 53,983 | $ | 61,022 | (11.5 | )% | |||||
Items not allocated at the segment level: | |||||||||||
Other operating expenses | 31,638 | 36,481 | (13.3 | )% | |||||||
Litigation and other gains | — | (485 | ) | N/M | |||||||
Depreciation and amortization | 6,391 | 7,151 | (10.6 | )% | |||||||
Total operating income (loss) | 15,954 | 17,875 | (10.7 | )% | |||||||
Other income (expense), net | 1,032 | (3,829 | ) | N/M | |||||||
Income from continuing operations before taxes | $ | 16,986 | $ | 14,046 | 20.9 | % | |||||
Other Operating Data: | |||||||||||
Number of full-time billable consultants (at period end) (1): | |||||||||||
Healthcare | 855 | 833 | 2.6 | % | |||||||
Business Advisory | 943 | 883 | 6.8 | % | |||||||
Education | 780 | 673 | 15.9 | % | |||||||
Total | 2,578 | 2,389 | 7.9 | % | |||||||
Average number of full-time billable consultants (for the period) (1): | |||||||||||
Healthcare | 876 | 828 | |||||||||
Business Advisory | 925 | 870 | |||||||||
Education | 787 | 664 | |||||||||
Total | 2,588 | 2,362 |
Three Months Ended June 30, | ||||||||
Other Operating Data (continued): | 2020 | 2019 | ||||||
Full-time billable consultant utilization rate (2): | ||||||||
Healthcare | 67.6 | % | 80.8 | % | ||||
Business Advisory | 75.8 | % | 73.1 | % | ||||
Education | 73.4 | % | 78.3 | % | ||||
Total | 72.4 | % | 77.2 | % | ||||
Full-time billable consultant average billing rate per hour (3): | ||||||||
Healthcare | $ | 219 | $ | 224 | ||||
Business Advisory (4) | $ | 201 | $ | 193 | ||||
Education | $ | 191 | $ | 200 | ||||
Total (4) | $ | 203 | $ | 206 | ||||
Revenue per full-time billable consultant (in thousands): | ||||||||
Healthcare | $ | 66 | $ | 84 | ||||
Business Advisory | $ | 73 | $ | 69 | ||||
Education | $ | 68 | $ | 74 | ||||
Total | $ | 69 | $ | 76 | ||||
Average number of full-time equivalents (for the period) (5): | ||||||||
Healthcare | 280 | 271 | ||||||
Business Advisory | 25 | 13 | ||||||
Education | 60 | 43 | ||||||
Total | 365 | 327 | ||||||
Revenue per full-time equivalent (in thousands): | ||||||||
Healthcare | $ | 97 | $ | 120 | ||||
Business Advisory | $ | 128 | $ | 166 | ||||
Education | $ | 147 | $ | 167 | ||||
Total | $ | 107 | $ | 128 |
Six Months Ended June 30, | Percent Increase (Decrease) | ||||||||||
Segment and Consolidated Operating Results (in thousands): | 2020 | 2019 | |||||||||
Healthcare: | |||||||||||
Revenues | $ | 180,934 | $ | 195,621 | (7.5 | )% | |||||
Operating income | $ | 45,221 | $ | 61,195 | (26.1 | )% | |||||
Segment operating income as a percentage of segment revenues | 25.0 | % | 31.3 | % | |||||||
Business Advisory: | |||||||||||
Revenues | $ | 135,375 | $ | 121,083 | 11.8 | % | |||||
Operating income | $ | 26,526 | $ | 21,055 | 26.0 | % | |||||
Segment operating income as a percentage of segment revenues | 19.6 | % | 17.4 | % | |||||||
Education: | |||||||||||
Revenues | $ | 124,167 | $ | 108,495 | 14.4 | % | |||||
Operating income | $ | 29,244 | $ | 28,822 | 1.5 | % | |||||
Segment operating income as a percentage of segment revenues | 23.6 | % | 26.6 | % | |||||||
Total Company: | |||||||||||
Revenues | $ | 440,476 | $ | 425,199 | 3.6 | % | |||||
Reimbursable expenses | 22,273 | 42,151 | (47.2 | )% | |||||||
Total revenues and reimbursable expenses | $ | 462,749 | $ | 467,350 | (1.0 | )% | |||||
Statements of Operations reconciliation: | |||||||||||
Segment operating income | $ | 100,991 | $ | 111,072 | (9.1 | )% | |||||
Items not allocated at the segment level: | |||||||||||
Other operating expenses | 58,784 | 73,059 | (19.5 | )% | |||||||
Litigation and other gains, net | (150 | ) | (941 | ) | (84.1 | )% | |||||
Depreciation and amortization expense | 12,438 | 14,323 | (13.2 | )% | |||||||
Goodwill impairment charges (6) | 59,816 | — | N/M | ||||||||
Total operating income (loss) | (29,897 | ) | 24,631 | N/M | |||||||
Other expense, net | (6,605 | ) | (5,870 | ) | 12.5 | % | |||||
Income (loss) from continuing operations before taxes | $ | (36,502 | ) | $ | 18,761 | N/M | |||||
Other Operating Data: | |||||||||||
Number of full-time billable consultants (at period end) (1): | |||||||||||
Healthcare | 855 | 833 | 2.6 | % | |||||||
Business Advisory | 943 | 883 | 6.8 | % | |||||||
Education | 780 | 673 | 15.9 | % | |||||||
Total | 2,578 | 2,389 | 7.9 | % | |||||||
Average number of full-time billable consultants (for the period) (1): | |||||||||||
Healthcare | 887 | 824 | |||||||||
Business Advisory | 922 | 854 | |||||||||
Education | 782 | 648 | |||||||||
Total | 2,591 | 2,326 |
Six Months Ended June 30, | ||||||||
Other Operating Data (continued): | 2020 | 2019 | ||||||
Full-time billable consultant utilization rate (2): | ||||||||
Healthcare | 69.6 | % | 79.7 | % | ||||
Business Advisory | 73.7 | % | 73.1 | % | ||||
Education | 74.8 | % | 77.4 | % | ||||
Total | 72.7 | % | 76.6 | % | ||||
Full-time billable consultant average billing rate per hour (3): | ||||||||
Healthcare | $ | 224 | $ | 224 | ||||
Business Advisory (4) | $ | 199 | $ | 196 | ||||
Education | $ | 189 | $ | 202 | ||||
Total (4) | $ | 204 | $ | 208 | ||||
Revenue per full-time billable consultant (in thousands): | ||||||||
Healthcare | $ | 139 | $ | 163 | ||||
Business Advisory | $ | 140 | $ | 137 | ||||
Education | $ | 136 | $ | 147 | ||||
Total | $ | 139 | $ | 149 | ||||
Average number of full-time equivalents (for the period) (5): | ||||||||
Healthcare | 279 | 247 | ||||||
Business Advisory | 22 | 11 | ||||||
Education | 60 | 39 | ||||||
Total | 361 | 297 | ||||||
Revenue per full-time equivalent (in thousands): | ||||||||
Healthcare | $ | 205 | $ | 248 | ||||
Business Advisory | $ | 275 | $ | 361 | ||||
Education | $ | 292 | $ | 332 | ||||
Total | $ | 224 | $ | 263 |
(1) | Consists of full-time professionals who provide consulting services and generate revenues based on the number of hours worked. |
(2) | Utilization rate for full-time billable consultants is calculated by dividing the number of hours full-time billable consultants worked on client assignments during a period by the total available working hours for these consultants during the same period, assuming a forty-hour work week, less paid holidays and vacation days. |
(3) | Average billing rate per hour for full-time billable consultants is calculated by dividing revenues for a period by the number of hours worked on client assignments during the same period. |
(4) | The Business Advisory segment includes operations of Huron Eurasia India. Absent the impact of Huron Eurasia India, the average billing rate per hour for the Business Advisory segment would have been $220 and $215 for the three months ended June 30, 2020 and 2019, respectively; and $222 and $219 for the six months ended June 30, 2020 and 2019, respectively. |
(5) | Consists of coaches and their support staff within the Culture and Organizational Excellence solution, consultants who work variable schedules as needed by clients, employees who provide managed services in our Healthcare segment, and full-time employees who provide software support and maintenance services to clients. |
(6) | The non-cash goodwill impairment charges are not allocated at the segment level because the underlying goodwill asset is reflective of our corporate investment in the segments. We do not include the impact of goodwill impairment charges in our evaluation of segment performance. |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2020 | 2019 | 2020 | 2019 | ||||||||||||
Revenues | $ | 217,857 | $ | 220,754 | $ | 440,476 | $ | 425,199 | |||||||
Net income (loss) from continuing operations | $ | 13,572 | $ | 10,569 | $ | (28,701 | ) | $ | 13,919 | ||||||
Add back: | |||||||||||||||
Income tax expense (benefit) | 3,414 | 3,477 | (7,801 | ) | 4,842 | ||||||||||
Interest expense, net of interest income | 2,916 | 4,524 | 5,257 | 8,782 | |||||||||||
Depreciation and amortization | 7,527 | 8,322 | 14,942 | 16,611 | |||||||||||
Earnings (loss) before interest, taxes, depreciation and amortization (EBITDA) (7) | 27,429 | 26,892 | (16,303 | ) | 44,154 | ||||||||||
Add back: | |||||||||||||||
Restructuring and other charges | 109 | 754 | 2,567 | 2,029 | |||||||||||
Litigation and other gains | — | (485 | ) | (150 | ) | (941 | ) | ||||||||
Goodwill impairment charges | — | — | 59,816 | — | |||||||||||
Loss on sale of business | — | — | 102 | — | |||||||||||
Transaction-related expenses | — | 2,050 | — | 2,050 | |||||||||||
Foreign currency transaction losses (gains), net | (81 | ) | 4 | 439 | (78 | ) | |||||||||
Adjusted EBITDA (7) | $ | 27,457 | $ | 29,215 | $ | 46,471 | $ | 47,214 | |||||||
Adjusted EBITDA as a percentage of revenues (7) | 12.6 | % | 13.2 | % | 10.6 | % | 11.1 | % |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2020 | 2019 | 2020 | 2019 | ||||||||||||
Net income (loss) from continuing operations | $ | 13,572 | $ | 10,569 | $ | (28,701 | ) | $ | 13,919 | ||||||
Weighted average shares - diluted | 22,116 | 22,400 | 21,848 | 22,356 | |||||||||||
Diluted earnings (loss) per share from continuing operations | $ | 0.61 | $ | 0.47 | $ | (1.31 | ) | $ | 0.62 | ||||||
Add back: | |||||||||||||||
Amortization of intangible assets | 3,194 | 4,314 | 6,403 | 8,831 | |||||||||||
Restructuring and other charges | 109 | 754 | 2,567 | 2,029 | |||||||||||
Litigation and other gains | — | (485 | ) | (150 | ) | (941 | ) | ||||||||
Goodwill impairment charges | — | — | 59,816 | — | |||||||||||
Non-cash interest on convertible notes | — | 2,145 | — | 4,265 | |||||||||||
Loss on sale of business | — | — | 102 | — | |||||||||||
Transaction-related expenses | — | 2,050 | — | 2,050 | |||||||||||
Tax effect of adjustments | (1,940 | ) | (2,282 | ) | (15,349 | ) | (4,235 | ) | |||||||
Total adjustments, net of tax | 1,363 | 6,496 | 53,389 | 11,999 | |||||||||||
Adjusted net income from continuing operations (7) | $ | 14,935 | $ | 17,065 | $ | 24,688 | $ | 25,918 | |||||||
Adjusted weighted average shares - diluted (8) | 22,116 | 22,400 | 22,223 | 22,356 | |||||||||||
Adjusted diluted earnings per share from continuing operations (7) | $ | 0.68 | $ | 0.76 | $ | 1.11 | $ | 1.16 |
(7) | In evaluating the company’s financial performance and outlook, management uses earnings (loss) before interest, taxes, depreciation and amortization (“EBITDA”), adjusted EBITDA, adjusted EBITDA as a percentage of revenues, adjusted net income from continuing operations, and adjusted diluted earnings per share from continuing operations, which are non-GAAP measures. Management uses these non-GAAP financial measures to gain an understanding of the company's comparative operating performance (when comparing such results with previous periods or forecasts). These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect the company's ongoing business in a manner that allows for meaningful period-to-period comparisons. Management also uses these non-GAAP financial measures when publicly providing the company's business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions. Management believes that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating Huron’s current operating performance and future prospects in the same manner as management does, if they so choose, and in comparing in a consistent manner Huron’s current financial results with Huron’s past financial results. Investors should recognize that these non-GAAP measures might not be comparable to similarly titled measures of other companies. These measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows or liquidity prepared in accordance with accounting principles generally accepted in the United States. |
(8) | As the company reported a net loss for the six months ended June 30, 2020, GAAP diluted weighted average shares outstanding equals the basic weighted average shares outstanding for that period. The non-GAAP adjustments described above resulted in adjusted net income from continuing operations for the first six months of 2020. Therefore, dilutive common stock equivalents have been included in the calculation of adjusted diluted weighted average shares outstanding. |